Eight major RCTs of GLP-1RAs have investigated the cardiovascular outcomes, including the ELIXA trial of lixisenatide (250), the EXSCEL trial of exenatide ER (251), the LEARDER trial of liraglutide (252), the SUSTAIN-6 trial of subcutaneous semaglutide (253), the HARMONY trial of albiglutide (228), the REWIND trial of dulaglutide (254), the PIONEER trial of oral semaglutide (255), and the SELECT trial of subcutaneous semaglutide (199)
Take that number to 10% and youll see improved live birth rates in overweight women seeking fertility treatment
Bar-Peled, L
Nutritious products must be accessible to GLP-1 users to achieve healthy eating habits that provide essential nutrients, vitamins, and minerals
Mounjaros Effectiveness Compared To Wegovy And Ozempic in Type 2 Diabetes & Weight Loss Mounjaro stands out like a powerful option for managing type 2 diabetes and promoting weight loss, especially in contrast to other GLP-1 receptor agonists such as Wegovy and Ozempic